Full Logo - OKYO .jpg
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
January 05, 2024 09:30 ET | OKYO Pharma LTD
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
400px-Blank_square.svg(1).jpg
Fortuna to attend Scotiabank Mining Conference
November 20, 2023 05:00 ET | Fortuna Silver Mines Inc.
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to announce that it will be attending the Scotiabank Mining Conference,...
tiziana-logo.png
Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023
November 01, 2023 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
tiziana-logo.png
Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress
October 11, 2023 07:00 ET | Tiziana Life Sciences Ltd.
Treatment Of Six Non-Active Secondary Progressive MS With Nasal Anti-CD3 Monoclonal Antibody (Foralumab): Safety, Biomarker, And Disability Outcomes
tiziana-logo.png
Tiziana Life Sciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 08, 2023 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
tiziana-logo.png
Tiziana Life Sciences Announces Foralumab Presentation by Dr. Howard Weiner at the Annual Meeting of the International Society of Neuroimmunology
August 23, 2023 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Gevo, Inc. Logo
Dr. Patrick Gruber to Participate in a Water Tower Research Fireside Chat on Thursday, August 17th at 4:00 pm ET
August 15, 2023 16:01 ET | Gevo, Inc.
ENGLEWOOD, Colo., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), announced today that Dr. Patrick Gruber, Chief Executive Officer, will participate in a Water Tower Research Fireside...
frontline-logo.png
FRO – Q1 2023 Presentation
May 31, 2023 08:49 ET | Frontline plc.
Please find enclosed the presentation of Frontline plc´s first quarter 2023 results to be held on the webcast / conference call 31 May, 2023 at 15:00 CET. This information is subject to the...
Mettler-Toledo International Inc. Announces Webcast of Presentation at the Jefferies Healthcare Conference
May 25, 2023 17:15 ET | Mettler-Toledo, LLC
Columbus, OH, May 25, 2023 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the Jefferies Healthcare Conference on Thursday, June...
HillmanLogo__Black.png
Hillman Announces Participation at Upcoming Investor Conferences During June 2023
May 23, 2023 07:30 ET | The Hillman Group
CINCINNATI, May 23, 2023 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, today announced...